Intravenous pentoxifylline as adjunct therapy to improve long-term disability in preterm infants

Phase 3

Recruiting

• Conditions: Late-onset sepsis (LOS); Preterm infants; Necrotising enterocolitis (NEC); Long-term disability; Reproductive Health and Childbirth - Complications of newborn; Inflammatory and Immune System - Other inflammatory or immune system disorders; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12616000405415
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-30
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1800

Inclusion Criteria

Gestation <29 weeks at birth.
< 6 hours (no later than 12 hours) from blood culture taken for suspected late-onset sepsis or NEC.
Informed parental consent.

Exclusion Criteria

Congenital malformations, chromosomal abnormalities or any other condition considered incompatible with disability-free survival at 24 months of age.

Study & Design

• Study Type: Interventional
• Study Design: Not specified